Sodium Hydrosulfide Protects Rats from Hypobaric-Hypoxia-Induced Acute Lung Injury
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms251910734 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Renjie Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Gansu University of Chinese Medicine, Lanzhou 730000, China. Hauptthemen laut MEDLINE: Acute Lung Injury, Sulfides, Oxidative Stress. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yue Gao, Traditional Chinese Medicine Innovation Team and Talent Support Program Project from the National Administration of Traditional Chinese Medicine.
Abstract (Originalsprache)
Hydrogen sulfide (H2S), as a key gas signaling molecule, plays an important role in regulating various diseases, with appropriate concentrations providing antioxidative, anti-inflammatory, and anti-apoptotic effects. The specific role of H2S in acute hypoxic injury remains to be clarified. This study focuses on the H2S donor sodium hydrosulfide (NaHS) and explores its protective effects and mechanisms against acute hypoxic lung injury. First, various mouse hypoxia models were established to evaluate H2S’s protection in hypoxia tolerance. Next, a rat model of acute lung injury (ALI) induced by hypoxia at 6500 m above sea level for 72 h was created to assess H2S’s protective effects and mechanisms. Evaluation metrics included blood gas analysis, blood routine indicators, lung water content, and lung tissue pathology. Additionally, LC-MS/MS and bioinformatic analyses were combined in performing quantitative proteomics on lung tissues from the normoxic control group, the hypoxia model group, and the hypoxia model group with NaHS treatment to preliminarily explore the protective mechanisms of H2S. Further, enzyme-linked immunosorbent assays (ELISA) were used to measure oxidative stress markers and inflammatory factors in rat lung tissues. Lastly, Western blot analysis was performed to detect Nrf2, HO-1, P-NF-κB, NF-κB, HIF-1α, Bcl-2, and Bax proteins in lung tissues. Results showed that H2S exhibited significant anti-hypoxic effects in various hypoxia models, effectively modulating blood gas and blood routine indicators in ALI rats, reducing pulmonary edema, improving lung tissue pathology, and alleviating oxidative stress, inflammatory responses, and apoptosis levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Gansu University of Chinese Medicine, Lanzhou 730000, China.
- Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.
- College of Pharmacy, Lanzhou University, Lanzhou 730000, China.
- Faculty of Environment and Life, Beijing University of Technology, Beijing 100083, China.
- National Key Laboratory of Kidney Diseases, Beijing 100850, China.
Förderung
- Yue Gao
- Traditional Chinese Medicine Innovation Team and Talent Support Program Project from the National Administration of Traditional Chinese Medicine
Zitieren
APA
Wang, R., Ma, S., Yang, J., Luo, K., Qian, Q., Pan, J., Liang, K., Wang, Y., Gao, Y., & Li, M. (2024). Sodium Hydrosulfide Protects Rats from Hypobaric-Hypoxia-Induced Acute Lung Injury. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910734
Vancouver
Wang R, Ma S, Yang J, Luo K, Qian Q, Pan J, et al. Sodium Hydrosulfide Protects Rats from Hypobaric-Hypoxia-Induced Acute Lung Injury. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910734
BibTeX
@article{Wang2024,
author = {Wang, Renjie and Ma, Shuhe and Yang, Jun and Luo, Kai and Qian, Qingyuan and Pan, Jinchao and Liang, Keke and Wang, Yihao and Gao, Yue and Li, Maoxing},
title = {Sodium Hydrosulfide Protects Rats from Hypobaric-Hypoxia-Induced Acute Lung Injury},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms251910734}
}
EUVIMED